Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDS Pharm CoXKRX:464280 40 Interest Coverage is 10.71 as of Jun. 2026, which is 36% below its 10-year median of 16.77. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 679 Drug Manufacturers companies, TDS Pharm Co ranks better than 58.62% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. TDS Pharm Co's
Operating Income
for the
three
months ended in Jun. 2026 was ₩1,043 Mil. TDS Pharm Co's Interest Expense for the
three
months ended in Jun. 2026 was ₩-97 Mil.
TDS Pharm Co's interest coverage for the quarter that ended in Jun. 2026 was 10.71.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for TDS Pharm Co's Interest Coverage or its related term are showing as below:
XKRX:464280'
s Interest Coverage Range Over the Past 10 Years
Min: 10.06 Med: 16.77 Max: 19.51
Current: 19.51
XKRX:464280's Interest Coverage is ranked better than 58.62% of 679
companies
in the Drug Manufacturers industry
Industry Median: 12.57
vs XKRX:464280: 19.51
TDS Pharm Co (XKRX:464280) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
TDS Pharm Co Interest Coverage Related Terms
TDS Pharm Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for TDS Pharm Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XKRX:464280 vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co (XKRX:464280) has a Interest Coverage of 10.71 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on TDS Pharm Co and its competitors. This is 36% below median its historical median of 16.77. Over the past decade, TDS Pharm Co's Interest Coverage has ranged from 10.06 to 19.51. According to the industry distribution chart, TDS Pharm Co ranks #281 out of 679 companies in the Drug Manufacturers industry, placing it in the top 41.4%.
Is TDS Pharm Co's Interest Coverage too high?
TDS Pharm Co's current Interest Coverage of 10.71 is 36% below median its 10-year median of 16.77. Over the past 10 years, this metric has ranged from a low of 10.06 to a high of 19.51. The Drug Manufacturers industry median Interest Coverage is 12.57. TDS Pharm Co's value of 10.71 is 14.8% below this industry median. Based on the distribution chart, TDS Pharm Co ranks #281 out of 679 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TDS Pharm Co ranks #281 out of 679 companies for Interest Coverage. This puts TDS Pharm Co in the upper half of its industry. The industry median Interest Coverage is 12.57. TDS Pharm Co's value of 10.71 is 14.8% below this benchmark. Historically, TDS Pharm Co's own Interest Coverage has ranged from 10.06 to 19.51 over the past decade. While the company's 10-year median is 16.77 vs. the industry median of 12.57, TDS Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.57, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TDS Pharm Co's current Interest Coverage of 10.71 is 14.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on TDS Pharm Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TDS Pharm Co's current Interest Coverage is 10.71, which is 36% below median its own 10-year median of 16.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Interest Coverage of 10.71. The current Interest Coverage is 10.71, which is 36% below median its 10-year median of 16.77 and 14.8% below the Drug Manufacturers industry median of 12.57. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Interest Coverage is 10.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
